{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T08:02:42Z","timestamp":1745049762123},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ogc.2006.05.010","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:08:25Z","timestamp":1168441705000},"page":"443-456","source":"Crossref","is-referenced-by-count":21,"title":["Thrombophilia and Adverse Pregnancy Outcome"],"prefix":"10.1016","volume":"33","author":[{"given":"Benjamin","family":"Brenner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ogc.2006.05.010_bib1","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2003-08-2744","article-title":"Clinical management of thrombophilia-related placental vascular complications","volume":"103","author":"Brenner","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib2","first-page":"132","article-title":"Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium","volume":"80","author":"Bremme","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2006.05.010_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Hemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Ballieres Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.ogc.2006.05.010_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V68.4.881.881","article-title":"Functional and immunologic protein S levels are decreased during pregnancy","volume":"68","author":"Comp","year":"1986","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ogc.2006.05.010_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2141.1995.tb05610.x","article-title":"Development of resistance to activated protein C during pregnancy","volume":"90","author":"Cumming","year":"1995","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ogc.2006.05.010_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ogc.2006.05.010_bib7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V69.2.460.460","article-title":"Fibrinolysis in pregnancy: a study of plasminogen activator and inhibitors","volume":"69","author":"Kruithof","year":"1987","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ogc.2006.05.010_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0009-9120(01)00205-3","article-title":"Reference interval of D-dimer in pregnant women","volume":"34","author":"Giavarina","year":"2001","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.ogc.2006.05.010_bib9","first-page":"776","article-title":"Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis","volume":"92","author":"Aharon","year":"2004","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ogc.2006.05.010_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","article-title":"The risk of abortion and stillbirth in antithrombin, protein C, and protein S-deficient women","volume":"75","author":"Sanson","year":"1996","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia: report on a study of the SSC Subcommittee on Fibrinogen","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ogc.2006.05.010_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(01)02971-5","article-title":"Thrombophilia is common in women with pregnancy loss and is associated with late pregnancy wastage","volume":"77","author":"Sarig","year":"2002","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ogc.2006.05.010_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.5858\/2002-126-1304-CUOFVL","article-title":"Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders","volume":"126","author":"Press","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.ogc.2006.05.010_bib14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.5858\/2002-126-1296-DSFTIW","article-title":"Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children","volume":"126","author":"Brenner","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.ogc.2006.05.010_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinardi","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ogc.2006.05.010_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2141.1997.882901.x","article-title":"Activated protein C resistance can be associated with recurrent fetal loss","volume":"97","author":"Brenner","year":"1997","journal-title":"Br J Haematol"},{"issue":"9361","key":"10.1016\/j.ogc.2006.05.010_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ogc.2006.05.010_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM200010053431405","article-title":"Mutations in coagulation factors in women with unexplained late fetal loss","volume":"343","author":"Martinelli","year":"2000","journal-title":"N Engl J Med"},{"issue":"9032","key":"10.1016\/j.ogc.2006.05.010_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ogc.2006.05.010_bib20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/humrep\/14.6.1624","article-title":"A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure","volume":"14","author":"Tal","year":"1999","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ogc.2006.05.010_bib21","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/j.1538-7836.2005.01609.x","article-title":"Thrombophilia and pregnancy loss in first intended pregnancy","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.ogc.2006.05.010_bib22","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2005.01581.x","article-title":"Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control \u2018NOHA first\u2019 study","volume":"3","author":"Lissalde-Lavigne","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ogc.2006.05.010_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low molecular weight heparin in pregnancy: a systemic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.ogc.2006.05.010_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0306-5456(01)00272-8","article-title":"Venous thromboembolism during pregnancy: a retrospective of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ogc.2006.05.010_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ogc.2006.05.010_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ogc.2006.05.010_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.ogc.2006.05.010_bib28","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ogc.2006.05.010_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ogc.2006.05.010_bib30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"LIVE-ENOX Investigators. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the LIVE-ENOX study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ogc.2006.05.010_bib31","first-page":"428","article-title":"Familial thrombophilia and the occurrence of fetal growth restriction","volume":"86","author":"Martinelli","year":"2001","journal-title":"Hematologica"},{"issue":"10","key":"10.1016\/j.ogc.2006.05.010_bib32","first-page":"177","article-title":"Low birth weight in neonates of mothers carrying factor V G1691A and factor A 20210 mutations","volume":"87","author":"Grandone","year":"2002","journal-title":"Hematologica"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM200207043470105","article-title":"Absence of association of thrombophilia polymorphisms with intrauterine growth restriction","volume":"347","author":"Infante-Rivard","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2006.05.010_bib35","series-title":"Haemostasis and thrombosis in obstetrics and gynaecology","first-page":"163","article-title":"Pathological processes in pregnancy-induced hypertension and intrauterine growth retardation \u2018an excess of heated blood.\u2019","author":"Greer","year":"1992"},{"issue":"5","key":"10.1016\/j.ogc.2006.05.010_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 [sFlt1] may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.ogc.2006.05.010_bib37","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J Clin Endocrin Metab"},{"issue":"12","key":"10.1016\/j.ogc.2006.05.010_bib38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1034\/j.1600-0412.2002.811201.x","article-title":"Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome","volume":"81","author":"Benedetto","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"10.1016\/j.ogc.2006.05.010_bib39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1055\/s-0038-1656110","article-title":"Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to pre-eclampsia","volume":"77","author":"Grandone","year":"1997","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ogc.2006.05.010_bib40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(99)70335-2","article-title":"Preeclampsia and genetic risk factors for thrombosis: a case control study","volume":"181","author":"De Groot","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2006.05.010_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review","volume":"87","author":"Morrison","year":"2002","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ogc.2006.05.010_bib42","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.0000188979.74172.4d","article-title":"Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study","volume":"46","author":"Mello","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"A low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Preg"},{"issue":"2","key":"10.1016\/j.ogc.2006.05.010_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0015-0282(02)03222-3","article-title":"Preventing adverse obstetric outcomes in women with genetic thrombophilia","volume":"78","author":"Grandone","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0301-2115(96)02383-4","article-title":"Hyper-homocystinemia: a risk factor for placental abruption or infarction","volume":"66","author":"Goddijn-Wessel","year":"1996","journal-title":"Eur J Ostet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ogc.2006.05.010_bib46","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ajcn\/71.4.962","article-title":"Plasma total homocysteine pregnancy complications and adverse pregnancy outcomes: the Hordaland Homocysteine study","volume":"71","author":"Vollset","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.ogc.2006.05.010_bib47","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0015-0282(00)01595-8","article-title":"Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis","volume":"74","author":"Nelen","year":"2000","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ogc.2006.05.010_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614594","article-title":"Case control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent\u2014the Nimes Obstetricians and Haematologists Study 5 (NOHA5)","volume":"81","author":"Gris","year":"1999","journal-title":"Thromb Haemost"},{"issue":"6 Pt 1","key":"10.1016\/j.ogc.2006.05.010_bib49","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9378(98)70025-0","article-title":"Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae","volume":"179","author":"Wiener-Megnagi","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2006.05.010_bib50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1471-0528.2003.02369.x","article-title":"Factor V Leiden in pregnancies complicated by placental abruption","volume":"110","author":"Prochazka","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ogc.2006.05.010_bib51","first-page":"980","article-title":"Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss","volume":"94","author":"Sarig","year":"2005","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.ogc.2006.05.010_bib52","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1538-7836.2005.01564.x","article-title":"Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment","volume":"3","author":"Aharon","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ogc.2006.05.010_bib53","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N Engl J Med"},{"issue":"7076","key":"10.1016\/j.ogc.2006.05.010_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ogc.2006.05.010_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2141.2001.02964.x","article-title":"Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss","volume":"114","author":"Franchi","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0037-1612657","article-title":"Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight","volume":"85","author":"Laude","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0037-1612654","article-title":"Procoagulant microparticles: new insights and opportunities in pregnancy loss?","volume":"85","author":"Greer","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ogc.2006.05.010_bib58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1613149","article-title":"Protein C global assay in the evaluation of women with idiopathic pregnancy loss","volume":"88","author":"Sarig","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2006.05.010_bib59","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2005-10-4111","article-title":"Feto-maternal cross-talk in the placental vascular bed: control of coagulation by trophoblast cells","volume":"107","author":"Sood","year":"2006","journal-title":"Blood"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854506000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854506000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T13:42:24Z","timestamp":1628343744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854506000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0889854506000544"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2006.05.010","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}